Equity Research Household & Personal Products

Should You Buy Adapti, Inc. Stock in 2026?

By CirclFi Research Team · · Updated · 1/13 models active

According to the CirclFi Deep Alpha Valuation Engine, Adapti, Inc. (ADTI) registers a weak Quality of Company score of 3.1/10. At the current price of $3.05, our 13-model framework evaluates whether the stock's discount is sufficient to compensate for high fundamental risks.

The short answer: 1 of 1 CirclFi valuation models project upside for Adapti, Inc. (ADTI) at $3.05 — the model consensus leans bullish, with a Quality Score of 3.1/10 and Value-Trap risk of 0/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 1 of 1 models see upside — majority bullish
  • Quality Score: 3.1/10 — Weak — below-average fundamentals
  • Value Trap Risk: 0/100 — Minimal — healthy fundamentals
  • Fair Value Range: $3.62 – $3.62 (0% spread)

Bullish Models

1 / 1

Bearish Models

0 / 1

Quality Score

3.1 /10

Weak — below-average fundamentals

Value Trap Risk

0 /100
Minimal

Minimal — healthy fundamentals

Model Consensus

1 /13
Active Models

Avg. confidence: 5%

What Is the Investment Case for Adapti, Inc. (ADTI) in 2026?

What Is the Bull Case vs the Bear Case for Adapti, Inc. (ADTI)?

Bull case versus bear case for Adapti, Inc. (ADTI) at $3.05, derived from 1 active CirclFi valuation models on 2026-08-27.
Bull case — $3.62 target (+18.6%) Bear case
According to the CirclFi Deep Alpha Valuation Engine, the gap between the market price of $3.05 and the median fair value of $3.62 implies +18.6% upside potential. No active model flags significant downside for ADTI. The low Value Trap score paints a constructive picture.
According to the CirclFi Deep Alpha Valuation Engine, the PWERM model targets a fair value of $3.62 (+18.6%), anchoring the bull case with a methodology that provides a differentiated analytical lens.
Industry tailwind: private label penetration could provide meaningful support for Adapti, Inc.'s revenue and margin trajectory in the Household & Personal Products space.

How Does ADTI Compare to Its Household & Personal Products Peers?

SKVI Skinvisible, Inc.
4.4
BYAH Park Ha Biological T
2.7
GROV Grove Collaborative
4.7
DSY Big Tree Cloud Holdi
2.4
XAGE Longevity Health Hol
4.7
TANH Tantech Holdings Ltd
1.4
ACU Acme United Corporat
8.3
ODD Oddity Tech Ltd.
7.6

Valuation data pages: SKVI · BYAH · GROV · DSY · XAGE · TANH · ACU · ODD · NWL · IPAR · PG

Which Other Stocks Score Like ADTI on Quality?

Closest companies to ADTI’s Quality of Company score of 3.1/10, across all industries.

Why Do CirclFi’s 1 Models Disagree on ADTI?

Spread

0%

Fair Value Range

$3.62 – $3.62

A tight 0% spread suggests meaningful convergence, strengthening conviction in the composite estimate.

Most Bullish

PWERM

$3.62 (+18.6%)

Most Bearish

PWERM

$3.62 (+18.6%)

What Are the Biggest Risks of Buying ADTI Stock?

Weak Fundamentals

QOC 3.1/10 signals below-average quality.

Macro/Sector Risk

Household & Personal Products headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View ADTI Data Page →

So Is Adapti, Inc. (ADTI) Worth Buying in 2026?

The convergence of 3.1/10 quality, multi-model undervaluation (1/1 bullish, +18.6% median upside), and a median fair value of $3.62 vs. $3.05 current price makes Adapti, Inc. one of the more compelling opportunities in our coverage. As always, our models provide a quantitative starting point — not a substitute for individual due diligence.

These are quantitative model outputs, not investment recommendations. Adapti, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

What Else Do Investors Ask About ADTI Stock?

Should I buy ADTI stock right now?

Based on CirclFi's multi-model analysis, 1 of 1 models see upside for ADTI at $3.05. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 3.1/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in Adapti, Inc.?

Key risks include: a below-average Quality Score of 3.1/10, indicating fundamental weakness; limited model coverage (1/13 active), reducing analytical confidence; general market and sector-specific risks affecting Household & Personal Products companies. Always diversify and consult a financial advisor.

How does ADTI compare to its competitors?

Among Household & Personal Products peers, ADTI holds a Quality Score of 3.1/10. Comparable companies include SKVI (QOC 4.4), BYAH (QOC 2.7), GROV (QOC 4.7). The relative ranking helps investors identify whether ADTI offers better fundamental quality than alternatives in the same sector.

Is ADTI a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. ADTI's Quality Score of 3.1/10 raises concerns about long-term viability without significant operational improvements. Check our full data page for all 13 model estimates.

What price should I buy ADTI at?

CirclFi does not provide target buy prices or price alerts. However, our 1 active models produce fair value estimates ranging from $3.62 to $3.62. At $3.05, the stock trades below even the most conservative estimate, which may represent a margin of safety — or reflect risks the models don't capture. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for ADTI.

View ADTI Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →